EXIMMIUM
LIVE

Serial Number

79404774

Owner

Eximmium Biotechnologies GmbH

Attorney

Ryan D. Artis

Filing Date

Apr 18, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EXIMMIUM Trademark

Serial Number: 79404774 • Registration: 8097692

EXIMMIUM is a trademark filed by Eximmium Biotechnologies GmbH on April 18, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Eximmium Biotechnologies GmbH

Feodor-Lynen-Straße 21

Entity Type: 99

Trademark Details

Filing Date

April 18, 2024

Registration Date

January 13, 2026

Published for Opposition

November 25, 2025

Goods & Services

Human healthcare services; animal healthcare services; medical services; medical and healthcare services; human hygiene and beauty care; advisory services relating to medical services; medical services in the field of oncology; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical diagnostic services.

Medical and veterinary preparations, namely, pharmaceutical and biological preparations for the treatment of cancer and infectious disease; Pharmaceuticals and natural remedies in the nature of pharmaceutical and biological preparations for the treatment of cancer and infectious disease; biotechnological preparations for the treatment of cancer and infectious disease for medical use; antibodies for medical purposes; diagnostic agents for medical use; diagnostic preparations and materials, namely, diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; anti-cancer drugs; Pharmaceutical compounds for treating cancer; pharmaceutical preparations and substances for use in oncology; clinical diagnostic reagents for medical use

Chemical substances, materials and preparations, namely, chemicals for industrial purposes; chemical compositions and materials, namely, chemicals for use in science; chemical components, namely, chemicals for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for scientific purposes for laboratory use; monoclonal antibodies for scientific use; tagged antibodies for scientific use; immunological antibodies for scientific purposes, other than for medical use; monoclonal antibodies for scientific purposes for diagnostic use, other than medical use; antibodies for scientific purposes, other than for medical or veterinary use; diagnostic preparations for scientific purposes; clinical diagnostics, namely, diagnostic reagents for scientific use other than for medical or veterinary use; diagnostic reagents for in-vitro use for scientific use, other than medical use; diagnostic reagents, other than for medical use in kit form, namely, diagnostic reagent kits for scientific use comprised of reagents for scientific use and test tubes

Science and technology services, namely, scientific research and development; natural science services, namely, scientific research; medical and pharmacological research services; information on the subject of scientific research in the field of biochemistry and biotechnology; research relating to biotechnology; biotechnology product testing; research and development in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific research laboratory services relating to the production of monoclonal antibodies; research and development in the field of diagnostic preparations

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 13, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 5, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 18, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 18, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 13, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 13, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 24, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 23, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 23, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 23, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 23, 2025 CNEA
ASSIGNED TO EXAMINER
Oct 3, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2025 TROA
ASSIGNED TO EXAMINER
Nov 30, 2024 DOCK
REFUSAL PROCESSED BY IB
Nov 30, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Nov 13, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 7, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 6, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 31, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 20, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 20, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 19, 2024 REPR